Characterization of the pharmacology of imidazolidinedione derivatives at cannabinoid CB1 and CB2 receptors

European Journal of Pharmacology
Sophie J GovaertsDidier M Lambert

Abstract

The pharmacology of 3-(2-ethylmorpholino)-5,5'-di(p-bromophenyl)-imidazolidinedione (DML20), 3-(1-hydroxypropyl)-5,5'-di(p-bromophenyl)-imidazolidinedione (DML21) and 3-heptyl-5,5'-di(p-bromophenyl)-imidazolidinedione (DML23) was extended by studying affinity and GTP binding modulation on cannabinoid receptor subtypes (CB1 and CB2) from rat tissues and human cannabinoid receptors expressed in Chinese Hamster Ovary cells. Competitive binding studies indicated that DML20, DML21 and DML23 are selective ligands for cannabinoid CB1 receptors. In rat cerebellum homogenates, DML20, DML21 and DML23 were unable to influence [35S]GTPgammaS binding but competitively inhibit HU 210-induced [35S]GTPgammaS binding (pKB of 6.11 +/- 0.14, 6.25 +/- 0.06 and 5.74 +/- 0.09, respectively), indicating that they act as cannabinoid CB1 receptor neutral antagonists. However, in CHO cells homogenates expressing selectively either human cannabinoid CB1 or CB2 receptors, they behaved as inverse agonists decreasing the [35S]GTPgammaS binding, with similar efficacy. In conclusion, these derivatives exhibit different activities (neutral antagonism and inverse agonism) in the different models of cannabinoid receptors studied.

References

May 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·K Mackie, B Hille
Oct 1, 1991·The Biochemical Journal·C M GérardM Parmentier
Mar 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·M HerkenhamK C Rice
Aug 1, 1995·Proceedings of the National Academy of Sciences of the United States of America·L J SimS R Childers
Feb 19, 1997·European Journal of Pharmacology·Y HosohataH I Yamamura
Nov 5, 1997·European Journal of Pharmacology·R S LandsmanH I Yamamura
Mar 13, 1998·Life Sciences·R S LandsmanH I Yamamura
Aug 5, 1998·British Journal of Pharmacology·S J MacLennanD W Bonhaus
Jul 28, 1999·European Journal of Pharmacology·B CalandraD Shire
Mar 10, 2001·European Journal of Pharmacology·L J Sim-SelleyD E Selley
May 31, 2002·Pharmacological Reviews·A C HowlettR G Pertwee
Jun 8, 2002·Prostaglandins, Leukotrienes, and Essential Fatty Acids·Beat Lutz
Jun 27, 2002·Biochimica Et Biophysica Acta·Sean M BrownKen Mackie
Aug 23, 2002·Chemical & Pharmaceutical Bulletin·Axel Reinhard StoitChris Gerrit Kruse
Feb 1, 2003·Trends in Pharmacological Sciences·Graeme Milligan

❮ Previous
Next ❯

Citations

Oct 19, 2004·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Sophie J GovaertsDidier M Lambert
Aug 23, 2007·Chemistry & Biodiversity·Eric Stern, Didier M Lambert
Aug 23, 2007·Chemistry & Biodiversity·Giulio G Muccioli
Aug 5, 2005·Journal of Medicinal Chemistry·Didier M Lambert, Christopher J Fowler

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Nature Reviews. Genetics
Steven L Teitelbaum, F Patrick Ross
BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology
Wouter H MoolenaarBen N G Giepmans
© 2022 Meta ULC. All rights reserved